Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2016 Filed Oct 4, 2016 18:08 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,894 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000426 · wf-form4_147560449809261.xml · derivative · entry 4 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,894 shares Expires 2016-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| October 02, 2016 Filed Oct 4, 2016 18:08 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
Tax withholdingCommon Stock | 1,801 | $80.26 | $144,548.26 |
DisclosureSEC source: 0000059478-16-000426 · wf-form4_147560449809261.xml · nonDerivative · entry 2 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,262 Read SEC document |
| October 02, 2016 Filed Oct 4, 2016 18:08 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
Exercise / conversionCommon Stock | 3,894 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000426 · wf-form4_147560449809261.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2016 Filed Oct 4, 2016 18:32 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,130 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000430 · wf-form4_147560591993472.xml · derivative · entry 5 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,130 shares Expires 2016-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2016 Filed Oct 4, 2016 18:32 UTC |
Crowe Maria APresident, Mfg. Operations
|
Tax withholdingCommon Stock | 1,884 | $80.26 | $151,209.84 |
DisclosureSEC source: 0000059478-16-000430 · wf-form4_147560591993472.xml · nonDerivative · entry 2 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,750 Read SEC document |
| October 02, 2016 Filed Oct 4, 2016 18:32 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionCommon Stock | 4,130 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000430 · wf-form4_147560591993472.xml · nonDerivative · entry 1 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 17:21 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 125 | $79.16 | $9,895.00 |
DisclosureSEC source: 0000059478-16-000422 · wf-form4_147560170183258.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,357 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 17:26 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 83 | $79.16 | $6,570.28 |
DisclosureSEC source: 0000059478-16-000424 · wf-form4_147560197486802.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,543 Read SEC document |
| August 31, 2016 Filed Sep 1, 2016 19:58 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,556 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000416 · wf-form4_147275990864052.xml · derivative · entry 4 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,556 shares Expires 2016-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| August 31, 2016 Filed Sep 1, 2016 19:58 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Tax withholdingCommon Stock | 3,033 | $77.77 | $235,876.41 |
DisclosureSEC source: 0000059478-16-000416 · wf-form4_147275990864052.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,513 Read SEC document |
| August 31, 2016 Filed Sep 1, 2016 19:58 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
Exercise / conversionCommon Stock | 6,556 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000416 · wf-form4_147275990864052.xml · nonDerivative · entry 1 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2016 Filed Sep 1, 2016 20:04 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 82 | $80.26 | $6,581.32 |
DisclosureSEC source: 0000059478-16-000418 · wf-form4_147276024465301.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,163 Read SEC document |
| August 31, 2016 Filed Sep 1, 2016 20:06 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 124 | $80.26 | $9,952.24 |
DisclosureSEC source: 0000059478-16-000420 · wf-form4_147276040163709.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,026 Read SEC document |
| August 24, 2016 Filed Jan 30, 2018 21:06 UTC |
Crowe Maria APresident, Mfg. Operations
|
GiftCommon Stock | 752 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000018 · wf-form5_151734640031769.xml · nonDerivative · entry 3 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,517 F1 · kind: This transaction represents a 2016 charitable gift contribution. Read SEC document |
| August 23, 2016 Filed Jan 27, 2017 16:37 UTC |
LECHLEITER JOHN CDirector
|
GiftCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000010 · wf-form5_148553501798236.xml · nonDerivative · entry 8 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 717,244 Read SEC document |
| August 15, 2016 Filed Aug 18, 2016 00:21 UTC Amendment |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 2,560 | $80.42 | $205,875.20 |
DisclosureSEC source: 0000059478-16-000412 · wf-form4a_147147969018297.xml · nonDerivative · entry 3 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,323 F1 · date: This amendment is being filed to correct the transaction date on the previously filed Form 4. F2 · price: This transaction was executed in multiple trades at prices ranging from $80.42 to $80.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 12, 2016 Filed Aug 16, 2016 12:51 UTC |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 2,560 | $80.42 | $205,875.20 |
DisclosureSEC source: 0000059478-16-000410 · wf-form4_147135189555621.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,110 F1 · acquired: This transaction was executed in multiple trades at prices ranging from $80.42to $80.43. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 12, 2016 Filed Aug 18, 2016 00:21 UTC Amendment |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 457 | $80.00 | $36,560.00 |
DisclosureSEC source: 0000059478-16-000412 · wf-form4a_147147969018297.xml · nonDerivative · entry 2 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,763 Read SEC document |
| August 11, 2016 Filed Aug 18, 2016 00:21 UTC Amendment |
TAI JACKSON PDirector
|
PurchaseCommon Stock | 2,756 | $80.52 | $221,913.12 |
DisclosureSEC source: 0000059478-16-000412 · wf-form4a_147147969018297.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,306 Read SEC document |
| August 11, 2016 Filed Jan 27, 2017 16:37 UTC |
LECHLEITER JOHN CDirector
|
GiftCommon Stock | 18,060 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000010 · wf-form5_148553501798236.xml · nonDerivative · entry 7 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 717,894 Read SEC document |
| August 03, 2016 Filed Aug 5, 2016 15:08 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000408 · wf-form4_147040968568771.xml · derivative · entry 6 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2016-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| August 03, 2016 Filed Aug 5, 2016 15:08 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Tax withholdingCommon Stock | 3,527 | $83.32 | $293,869.64 |
DisclosureSEC source: 0000059478-16-000408 · wf-form4_147040968568771.xml · nonDerivative · entry 2 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,618 Read SEC document |
| August 03, 2016 Filed Aug 5, 2016 15:08 UTC |
Walsh Fionnuala MSVP, Global Quality
|
Exercise / conversionCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000408 · wf-form4_147040968568771.xml · nonDerivative · entry 1 Walsh Fionnuala M · CIK 0001524637 · SVP, Global Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2016 Filed Aug 1, 2016 15:34 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 124 | $79.95 | $9,913.80 |
DisclosureSEC source: 0000059478-16-000404 · wf-form4_147006564690791.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,902 Read SEC document |
| July 29, 2016 Filed Aug 1, 2016 15:38 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 82 | $79.95 | $6,555.90 |
DisclosureSEC source: 0000059478-16-000406 · wf-form4_147006592235049.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,081 Read SEC document |
| July 29, 2016 Filed Aug 1, 2016 17:29 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 205,000 | $82.94 | $17,001,880.00 |
DisclosureSEC source: 0001209191-16-134556 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,775,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.66 to $83.15, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 28, 2016 Filed Jul 29, 2016 17:23 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 1,213 | $83.16 | $100,873.08 |
DisclosureSEC source: 0000059478-16-000402 · wf-form4_146981299287458.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Read SEC document |
| July 28, 2016 Filed Jul 29, 2016 17:57 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 39,766 | $83.13 | $3,305,588.52 |
DisclosureSEC source: 0001209191-16-134407 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,980,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.07 to $83.19, inclusive. Read SEC document |
| July 28, 2016 Filed Jul 29, 2016 17:57 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 200,234 | $82.82 | $16,582,979.41 |
DisclosureSEC source: 0001209191-16-134407 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,020,570 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.07 to $83.06, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 12, 2016 Filed Jul 13, 2016 14:49 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 210,000 | $79.54 | $16,703,820.00 |
DisclosureSEC source: 0001209191-16-132483 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,220,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.285 to $79.83, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 07, 2016 Filed Jul 8, 2016 17:06 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 11,705 | $79.71 | $933,017.26 |
DisclosureSEC source: 0001209191-16-132119 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,430,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.65 to $79.76, inclusive. Read SEC document |
| July 07, 2016 Filed Jul 8, 2016 17:06 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 213,295 | $79.11 | $16,873,340.86 |
DisclosureSEC source: 0001209191-16-132119 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,442,509 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.65 to $79.64, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 30, 2016 Filed Jun 30, 2016 20:53 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 135 | $73.28 | $9,892.80 |
DisclosureSEC source: 0000059478-16-000387 · wf-form4_146732001349022.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,778 Read SEC document |
| June 30, 2016 Filed Jun 30, 2016 20:56 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 90 | $73.28 | $6,595.20 |
DisclosureSEC source: 0000059478-16-000389 · wf-form4_146732015655861.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,999 Read SEC document |
| June 30, 2016 Filed Jul 1, 2016 15:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 152,900 | $78.60 | $12,017,634.20 |
DisclosureSEC source: 0001209191-16-130365 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,655,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.49 to $78.805, inclusive. Read SEC document |
| June 30, 2016 Filed Jul 1, 2016 15:36 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 62,100 | $78.14 | $4,852,307.70 |
DisclosureSEC source: 0001209191-16-130365 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,808,704 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.49 to $78.485, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 29, 2016 Filed Jun 30, 2016 19:14 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 92,981 | $78.09 | $7,260,421.39 |
DisclosureSEC source: 0001209191-16-130204 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,870,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.96 to $78.24, inclusive. Read SEC document |
| June 29, 2016 Filed Jun 30, 2016 19:14 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 127,019 | $77.70 | $9,868,741.21 |
DisclosureSEC source: 0001209191-16-130204 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,963,785 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.96 to $77.955, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| June 10, 2016 Filed Jun 13, 2016 20:19 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
GiftCommon Stock | 2,541 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-16-000379 · wf-form4_146584917758562.xml · nonDerivative · entry 2 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,169 Read SEC document |
| June 10, 2016 Filed Jun 13, 2016 20:19 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
SaleCommon Stock | 992 | $73.77 | $73,179.84 |
DisclosureSEC source: 0000059478-16-000379 · wf-form4_146584917758562.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,710 Read SEC document |
| June 01, 2016 Filed Jan 27, 2017 17:16 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
GiftCommon Stock | 4,450 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000017 · wf-form5_148553737544063.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,958 Read SEC document |
| May 31, 2016 Filed Jun 1, 2016 17:48 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 127 | $78.29 | $9,942.83 |
DisclosureSEC source: 0000059478-16-000375 · wf-form4_146480328050263.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,425 Read SEC document |
| May 31, 2016 Filed Jun 1, 2016 17:51 UTC |
MARRAM ELLEN RDirector
|
GrantCommon Stock | 84 | $78.29 | $6,576.36 |
DisclosureSEC source: 0000059478-16-000377 · wf-form4_146480348075513.xml · nonDerivative · entry 1 MARRAM ELLEN R · CIK 0001234124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,592 Read SEC document |
| May 31, 2016 Filed Jun 1, 2016 18:49 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 200,000 | $75.12 | $15,023,200.00 |
DisclosureSEC source: 0001209191-16-124593 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,090,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.72 to $75.50, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| May 24, 2016 Filed Jan 27, 2017 16:37 UTC |
LECHLEITER JOHN CDirector
|
GiftCommon Stock | 1,110 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000010 · wf-form5_148553501798236.xml · nonDerivative · entry 6 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735,954 Read SEC document |
| May 20, 2016 Filed Jan 27, 2017 16:37 UTC |
LECHLEITER JOHN CDirector
|
GiftCommon Stock | 740 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000010 · wf-form5_148553501798236.xml · nonDerivative · entry 5 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,064 Read SEC document |
| May 19, 2016 Filed Jan 27, 2017 17:11 UTC |
Ricks David ADirector · President & CEO
|
GiftCommon Stock | 105 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000015 · wf-form5_148553709843634.xml · nonDerivative · entry 1 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,298 Read SEC document |
| May 13, 2016 Filed Jan 27, 2017 16:37 UTC |
LECHLEITER JOHN CDirector
|
GiftCommon Stock | 3,314 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000010 · wf-form5_148553501798236.xml · nonDerivative · entry 4 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,804 Read SEC document |
| May 12, 2016 Filed May 13, 2016 19:09 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,106 | $76.60 | $391,119.60 |
DisclosureSEC source: 0001209191-16-119838 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,290,804 F2 · price: The price reported in Column 4 is a weighted average price of $76.600. These shares were sold in multiple transactions at prices ranging from $76.41 to $76.67, inclusive. Read SEC document |
| May 12, 2016 Filed May 13, 2016 19:09 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 184,894 | $75.84 | $14,022,915.64 |
DisclosureSEC source: 0001209191-16-119838 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,295,910 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.36 to $76.30, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.